| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 1,683 | 1,683 |
| Net (decrease) increase in cash, cash equivalents, and restricted cash | -4,635 | -2,257 |
| Cash and cash equivalents at beginning of period | 11,455 | - |
| Cash and cash equivalents at end of period | 6,820 | - |
VivoSim Labs, INC. (VIVS)
VivoSim Labs, INC. (VIVS)